CYDY

$0.23+4.55%

CytoDyn Inc.

Market Cap

$338M

Live price × SEC shares (Sep 30, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.65

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Aug 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

N/M

TTM to Aug 2026 · negative equity

EV/EBITDA (TTM)

N/M

TTM to Aug 2026 · negative EBITDA

Loading…

Financial Statements

USD thousands	Q2 FY2026 Nov 30, 2025	Q3 FY2026 Feb 28, 2026	Q4 FY2026 May 31, 2026	Q1 FY2027 Aug 31, 2026	TTM Aug 31, 2026
Operating income	(21,688)	(6,303)	(5,639)	(6,577)	(40,207)
Pretax income	(22,607)	(4,690)	(9,862)	(19,936)	(57,095)
Income tax	0.00	0.00	0.00	0.00	0.00
Net income	(22,607)	(4,690)	(9,862)	(19,936)	(57,095)
EPS (basic) ($)	(0.02)	0.00		(0.01)	(0.04)
EPS (diluted) ($)	(0.02)	0.00		(0.01)	(0.04)
Weighted avg. shares (basic)	1,261,016	1,275,184		1,382,223
Weighted avg. shares (diluted)	1,261,016	1,275,184		1,382,223

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Oct 14, 2026, period ended Aug 31, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Aug 2010, with Tormere Pro.

Corporate Events (8-K)

6 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Oct 19, 2026 accepted 8:50 PM ET	5.02Officer / director change7.01Reg FD disclosure	Document SEC ↗
Apr 30, 2026 accepted 8:32 PM ET	7.01Reg FD disclosure	Document SEC ↗
Mar 24, 2026 accepted 9:15 PM ET	1.01Material agreement	Document SEC ↗
Mar 5, 2026 accepted 1:35 PM ET	3.02Unregistered equity sale	Document SEC ↗
Dec 1, 2025 accepted 1:40 PM ET	8.01Other events	Document SEC ↗
Nov 21, 2025 accepted 10:15 PM ET	5.03Bylaws / fiscal year5.07Shareholder vote	Document SEC ↗
Nov 3, 2025 accepted 1:38 PM ET	1.01Material agreement3.02Unregistered equity sale7.01Reg FD disclosure	Document SEC ↗
May 16, 2025 accepted 9:15 PM ET	4.01Auditor change	Document SEC ↗
May 6, 2025 accepted 9:05 PM ET	5.02Officer / director change7.01Reg FD disclosure	Document SEC ↗
Nov 22, 2024 accepted 10:15 PM ET	5.07Shareholder vote	Document SEC ↗